Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

@inproceedings{Troughton2014EffectOB,
  title={Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis},
  author={Richard W. Troughton and C M Frampton and Hans-Peter Brunner-la Rocca and Matthias P Pfisterer and Luc W.M. Eurlings and Hans Erntell and Hans Persson and Christopher M. O'Connor and Deddo Moertl and Patric Karlstr{\"o}m and Ulf Dahlstr{\"o}m and Hanna Kim Gaggin and James Louis Januzzi and Rudolf Berger and Arthur Mark Richards and Yigal M. Pinto and M. G. Nicholls},
  booktitle={European heart journal},
  year={2014}
}
AIMS Natriuretic peptide-guided (NP-guided) treatment of heart failure has been tested against standard clinically guided care in multiple studies, but findings have been limited by study size. We sought to perform an individual patient data meta-analysis to evaluate the effect of NP-guided treatment of heart failure on all-cause mortality. METHODS AND RESULTS Eligible randomized clinical trials were identified from searches of Medline and EMBASE databases and the Cochrane Clinical Trials… CONTINUE READING